Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes

NCT04164966 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT04164966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04164966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes
Lead sponsor
AdventHealth Translational Research Institute
Phase
Observational
Overall status
Active, not recruiting
Start date
November 27, 2019
Completion date
December 31, 2026
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes